The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception · 2026
Patterns in contraception counseling among women with cardiovascular disease.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Panah Lindsay G, Adkins Elisabeth N, Rukavina Madeline, Wells Quinn S, Lowery Brandon D, Damp Julie B, Patel Soha S
Аннотация
BACKGROUND: Contraceptive counseling is an important component of cardiovascular care for women of reproductive age with cardiovascular disease (CD).
OBJECTIVES: We evaluated the prevalence of contraceptive counseling by cardiologists in women of reproductive age with CD.
METHODS: We conducted a cross-sectional survey of women aged 18-45 with CD, assessing obstetric history, contraceptive counseling, and contraceptive use. Participants were categorized by CD type (congenital vs. acquired), World Health Organization (WHO) CD risk (I-II vs. III-IV), and teratogenic cardiovascular medication use.
RESULTS: Among 176 respondents, women with acquired CD were less likely to recall contraceptive counseling than those with congenital CD(11% vs. 39%, p < 0.001). High-risk patients (WHO III-IV) more frequently recalled counseling than low-risk patients (36% vs. 9%, p < 0.001). Only 21% of women taking teratogenic medications recalled counseling, and 42% were not using contraception. Contraceptive use did not differ by CD type (49% vs. 55%, p = 0.69).
CONCLUSIONS: Contraceptive counseling remains underutilized, highlighting an opportunity to improve reproductive and cardiovascular care.
OBJECTIVES: We evaluated the prevalence of contraceptive counseling by cardiologists in women of reproductive age with CD.
METHODS: We conducted a cross-sectional survey of women aged 18-45 with CD, assessing obstetric history, contraceptive counseling, and contraceptive use. Participants were categorized by CD type (congenital vs. acquired), World Health Organization (WHO) CD risk (I-II vs. III-IV), and teratogenic cardiovascular medication use.
RESULTS: Among 176 respondents, women with acquired CD were less likely to recall contraceptive counseling than those with congenital CD(11% vs. 39%, p < 0.001). High-risk patients (WHO III-IV) more frequently recalled counseling than low-risk patients (36% vs. 9%, p < 0.001). Only 21% of women taking teratogenic medications recalled counseling, and 42% were not using contraception. Contraceptive use did not differ by CD type (49% vs. 55%, p = 0.69).
CONCLUSIONS: Contraceptive counseling remains underutilized, highlighting an opportunity to improve reproductive and cardiovascular care.